Prof Peter Hillmen discusses exciting new data in CLL from EHA19

Professor Peter Hillmen from Leeds Teaching Hospital in the UK explains the latest research results as presented at the EHA on new treatments Ibrutinib and Idelalisib, and how they offer great promise... Author: PatientPowerEU Added: 06/27/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts